8-K: GoHealth Reports 2025 Results, Prioritizes Cash & SNP

GoHealth, Inc. announced its full-year 2025 financial results, revealing an intentional pullback in Medicare Advantage activity and a focus on consumer fit, renewal economics, and cash discipline.

Summary

• Net revenues decreased significantly by 54.7% to $361.8 million for the twelve months ended December 31, 2025, from $798.9 million in 2024.
• The net loss attributable to GoHealth, Inc. widened substantially to $(257.1) million in 2025, compared to a net loss of $(2.9) million in 2024.
• Adjusted EBITDA shifted from a positive $120.3 million in 2024 to a negative $(35.1) million in 2025.
• The company reported an intentional pullback in Medicare Advantage activity in 2025, driven by market realities and a focus on consumer fit and renewal economics.
• GoHealth continued its leadership in Special Needs Plans (SNP) populations.
• Targeted investments were made in proprietary agentic AI and automation to lower customer acquisition costs and improve efficiency.
• Submissions decreased by 47.4% from 1,016,182 in 2024 to 534,657 in 2025.
• Sales per Submission decreased by 14.5% from $781 in 2024 to $668 in 2025.
• Direct Operating Cost per Submission increased by 2.8% from $578 in 2024 to $594 in 2025.
• An indefinite and long-lived asset impairment charge of $259.961 million was recorded in 2025.
• Net cash used in operating activities increased to $(121.9) million in 2025 from $(21.6) million in 2024.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a challenging report, reflecting a significant decline in key financial metrics and a substantial net loss, even with the stated intentional strategic pullback. While the focus on cash discipline and SNP leadership is positive, the overall financial performance indicates a difficult operating environment and a need for substantial turnaround.

Positives

• Delivered materially improved year-over-year retention, reinforcing cohort quality and proprietary PlanFit logic.
• Continued leadership in key Special Needs Plans (SNP) categories due to proprietary enrollment and servicing tools, technology, and experience.
• Continued targeted investment in built-for-purpose, proprietary agentic AI and automation to lower customer acquisition costs and improve efficiency.
• Optimized cash, protected the commissions receivable, and preserved operating flexibility.
• Maintaining high conviction that the fragmented broker landscape will consolidate, positioning GoHealth to lead disciplined integration opportunities.

Negatives

• Net revenues decreased by 54.7% to $361.8 million in 2025 from $798.9 million in 2024.
• Net loss attributable to GoHealth, Inc. significantly widened to $(257.1) million in 2025 from $(2.9) million in 2024.
• Adjusted EBITDA turned negative, from $120.3 million in 2024 to $(35.1) million in 2025.
• Submissions decreased by 47.4% to 534,657 in 2025.
• Sales per Submission decreased by 14.5% to $668 in 2025.
• Direct Operating Cost per Submission increased by 2.8% to $594 in 2025, indicating deteriorating unit economics.
• Incurred a $259.961 million indefinite and long-lived asset impairment charge in 2025.
• Net cash used in operating activities increased to $(121.9) million in 2025 from $(21.6) million in 2024.
• The Medicare Advantage market remains in a structural reset going into 2026, posing ongoing challenges.

Risks

• The Medicare Advantage market remains in a structural reset, with health plans continuing to prioritize retention, member quality, and disciplined unit economics, which could impact GoHealth's growth.
• Forward-looking statements are subject to risks, assumptions, and uncertainties that are difficult to predict, as detailed in the company's Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.
• Actual results may prove to be materially different from the expectations reflected in forward-looking statements due to various factors.

Future Outlook

The Medicare Advantage market is expected to remain in a structural reset going into 2026, with health plans continuing to prioritize retention, member quality, and disciplined unit economics. GoHealth aims to scale quickly when market conditions stabilize by maintaining a consumer-first approach, protecting liquidity, and investing in core capabilities. The company anticipates continued consolidation in the fragmented broker landscape and positions itself to lead disciplined integration opportunities.

Management Comments

• CEO Vijay Kotte: "The Medicare Advantage market remains in a structural reset going into 2026, and our view is that health plans continue to prioritize retention, member quality, and disciplined unit economics."
• CEO Vijay Kotte: "Our pullback in 2025 was intentional. In this environment, consumers need a trusted partner more than ever. Our focus is helping ensure members enroll in plans that truly fit their needs, even when that means confirming their current coverage remains the best option."
• CEO Vijay Kotte: "At the same time, we are maintaining disciplined focus on cash and improving our capital structure, while continuing tactical investments in technology and AI that improve efficiency today, support lower acquisition costs now and in the future, and position us to ramp quickly as conditions improve."
• CFO Brendan Shanahan: "Our full-year performance reflect disciplined execution in a market where health plans are prioritizing margin stability and member quality."
• CFO Brendan Shanahan: "Operating cash flow will remain the primary lens for our capital allocation decisions. As we move forward, we are concentrating investment where we have confidence in durable returns, strengthening retention, and continuing to improve efficiency through practical automation and AI."

Industry Context

StockSavvy.ai notes that GoHealth's strategic pullback in Medicare Advantage aligns with broader industry trends where health plans are shifting focus from aggressive enrollment growth to member retention, quality, and unit economics. This reflects a maturing market and increased scrutiny on profitability, impacting lead generation and commission structures for brokers. The emphasis on Special Needs Plans (SNP) also highlights a niche where targeted growth and stable member value are still prioritized by health plans, potentially offering a more resilient segment amidst broader market challenges.

Comparison to Industry Standards

• The significant decline in net revenues (54.7%) and the shift to negative Adjusted EBITDA contrast sharply with companies that have successfully navigated the Medicare Advantage market's 'structural reset' by diversifying offerings or maintaining strong organic growth in specific segments. For example, while some competitors might show slower growth, a 50%+ revenue decline suggests a more severe impact or a more aggressive strategic pivot than typically observed across the broader, more stable parts of the health insurance brokerage industry.
• The increase in Direct Operating Cost per Submission ($594 in 2025 vs. $578 in 2024) despite a decrease in Sales per Submission ($668 in 2025 vs. $781 in 2024) indicates deteriorating unit economics, which is a concern compared to industry leaders who typically strive for improving efficiency and cost control even in challenging markets.
• GoHealth's continued leadership in Special Needs Plans (SNP) could be a differentiating factor, as this segment often offers higher retention and more stable economics compared to general Medicare Advantage, potentially providing a buffer against broader market headwinds and aligning with health plan priorities for member stability.

Stakeholder Impact

• Shareholders: The significant net loss, negative Adjusted EBITDA, and substantial decline in revenues will likely negatively impact shareholder value and the company's stock price.
• Customers (Medicare enrollees): The "consumer-first approach" and focus on "plan fit" aim to benefit customers by ensuring appropriate coverage, potentially leading to better long-term outcomes for enrollees.
• Employees: The increase in severance costs from $2.480 million in 2024 to $11.550 million in 2025 indicates a reduction in workforce, negatively impacting employees.
• Health Plan Partners: GoHealth's intentional pullback in Medicare Advantage activity and focus on "member quality" and "renewal economics" aligns with health plans' priorities, potentially strengthening relationships, especially in the SNP segment.
• Creditors: The increase in long-term debt and negative operating cash flow could raise concerns for creditors, although management is focused on improving the capital structure and protecting liquidity.

Next Steps

• Continue tactical investments in technology and AI to improve efficiency and lower acquisition costs.
• Position the company to ramp quickly as market conditions improve.
• Lead disciplined integration opportunities in the fragmented broker landscape when appropriate.
• Concentrate investment where there is confidence in durable returns and strengthening retention.
• Continue to improve efficiency through practical automation and AI.
• Prepare and file the forthcoming Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Key Dates

Recommendation

The company reported a substantial decline in revenues, a significant net loss, and negative Adjusted EBITDA for 2025, indicating severe financial underperformance. While management cites an 'intentional pullback' in Medicare Advantage, the deteriorating unit economics (lower sales per submission, higher cost per submission) and increased debt levels raise significant concerns about the company's financial health and future growth prospects. The market reset for Medicare Advantage is a headwind, and despite strategic investments in AI and SNP, the overall financial trajectory suggests a 'sell' recommendation for investors seeking to avoid further downside risk.

Keywords

Medicare Advantage, Health Insurance, Special Needs Plans, AI, Digital Health, Financial Results, GOCO, Insurance Marketplace, Broker Consolidation, SEC Filing